期刊文献+

192例胰腺癌的外科治疗及随访 被引量:4

Surgical treatment of pancreatic cancer:a report of 192 cases
暂未订购
导出
摘要 目的 探讨胰腺癌的治疗方法对患者生存时间及生存率的影响 ,总结胰腺癌的治疗经验。 方法回顾分析1995年1月至2000年12月收治的192例胰腺癌患者的外科治疗情况 ,并对部分患者的随访结果进行研究。结果 146例手术治疗的患者手术切除率为47.26% ,根治性切除率为32.19 %。获得随访的55例患者中根治性切除组、姑息性切除组、姑息性捷径组、未手术组的1年生存率分别为51.14 %、20.41 %、8.04 %、0。结论 根治性切除仍是唯一有效的治疗方法 ,姑息性治疗并不能延长胰腺癌患者的生命 ,胰腺癌进行单一外科治疗的效果不乐观 。 Objectives To evaluate outcome of patients with pancreatic cancer under different surgical modalities,and to sum up the treatment experience for pancreatic cancer.Methods The records of 192 patients with pancreatic cancer at our hospital between 1995 and 2000 were reviewed retrospectively.Fifty five patients were followed-up.Results The surgical resection rate of 146 operable patients was 47.3%,with a radical resection rate of 32.2%.For 55 followed-up patients,the 1 year survival rate of radical resection,palliative resection,bypass,and no operation was 51.1%,20.4%,8.0%,0,respectively.Conclusion Radical resection is the only effective method,palliative treatment can not prolong the survival of patients.
出处 《浙江医学》 CAS 2002年第1期3-5,共3页 Zhejiang Medical Journal
关键词 胰腺癌 外科治疗 随访 Pancreatic cancer Surgical treatment Follow-up study
  • 相关文献

参考文献5

  • 1[1]Tsiotos GG, Farnell MB, Sarr MG. Are the results of pancreatectomy for pancreatic cancer improving?World J Surg, 1999,23(9):913.
  • 2[2]Yamamoto M, Ohashi O, Saitoh Y. Japan pancreatic cancer registry : current status. Pancreas, 1998, 16(3) : 238.
  • 3[3]Osamu Ishikawa,Hiroaki Ohigashi,Yo Sasaki,et al. Practical grouping of positive lymph nodes in pancreatic heed cancer treated by an extended pancreatectomy. Surgery, 1997,121:244.
  • 4[4]Wenger FA, Peter F, Zieren J, et al. Prognosis factors in carcioma of the head of the pancreas. Dig Surg, 2000, 17(1):29.
  • 5[5]Benassai G, Mastrerilli M, Quarto G, et al. Survival after pancreaticoduedenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital, 2000,52(3) : 263.

同被引文献38

  • 1苏震东,骆明德.K-ras基因突变在胰腺癌中的作用研究进展[J].国外医学(消化系疾病分册),2005,25(1):48-51. 被引量:4
  • 2何小平,朱人敏,王震凯,汪芳裕,张晓华,刘炯,王琳.重组Canstatin蛋白联合氟尿嘧啶治疗胰腺癌[J].世界华人消化杂志,2006,14(35):3353-3357. 被引量:8
  • 3韩锐 主编.抗癌药物研究与实验技术[M].北京:北京医科大学、中国协和医科大学联合出版社,1996.342.
  • 4Mong H. Tan, Rueyming Loor, Hisako Ochi, et al. Characterization of a New Primary Human Pancreatic Tumor Line [J ]. Cancer Investigation, 1986, 4 (1): 15~23
  • 5危北海.四君子汤的源流及运用[J].中国农村医学,1984,(1):53-54.
  • 6陈泽民 李道本 金敬善.全国中西医结合防治消化系统疾病对策研讨会论文述要[J].中国中西医结合杂志,1992,12(6):381-384.
  • 7邱佳信 杨金坤 唐莱娣.中药的反突变作用研究[J].中国中西医结合杂志,1994,14(5):268-268.
  • 8Cooperman AM. Pancreatic cancer: the bigger picture. Surg Clin North Am, 2001,81:557-574.
  • 9Wozniak M A, Kwong L, Chodniewicz D, et al. R-ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho[J]. Molecular Biology of the Cell, 2005 16( 1 ):84-96.
  • 10Coleman M L, Marshall C J, Olson M F, Ras and Rho GTPases in G1-phase cell-cycle regulation[J]. Nat Rev Mol Cell Biol, 2004, 5 (5):355-366.

引证文献4

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部